Program - The Australasian College of Dermatologists

Transcription

PRO
M
A
R
G
AUSTRALIA’S CITY OF CULTURE WELCOMES YOU TO
THE AUSTRALASIAN COLLEGE OF DERMATOLOGISTS
48TH ANNUAL SCIENTIFIC MEETING
SATURDAY 16 MAY to TUESDAY 19 MAY 2015
’ AS
SES
TIO
N
NC
E
R
E
IA
SOC
E
N F5
O
C
MA
L MAY 201
A
DER
TS
N
N
A
17
GIS
LI
O
O
Y
A
L
I
A
R
T
AT O
A TAND SUND
AUS
N
ERM
D
H
Y
TIC
SME
O
1 4URTDAY 16 MA
C
F
NG
I
Y O
T
T
E
E
I
SAT
E AY 2015
SOC
M
AN
I
L
S
A
A SDAY 19 M
U
RAL
T
S
N
AU
TUE
AN
ND
A
D
Y
2 N 18 MA
OG
TOL
MON
DAY
UR
Y N
A D EL AI D E C ON VEN TI ON C EN T R E , A D E L A ID E , SO UT H AUST R A LIA , AUST R A LIA
This brochure sets out the program and other information for the 48th Annual Scientific Meeting of the
Australasian College of Dermatologists in Adelaide. Also included are the programs for the satellite meetings
of the Australian Dermatology Nurses’ Association and the Australasian Society of Cosmetic Dermatologists.
The convenors of the meeting are Dr Karen Koh, Dr Priya Selva-Nayagam and Dr Sachin Vaidya. The
South Australian Faculty, on behalf of the College, welcomes Fellows, trainees, students and other medical
professionals to the meeting.
The Annual Scientific Meeting program incorporates major changes to the meeting previously adopted by the
College. The meeting is now of four days’ duration, commencing on Saturday and finishing on Tuesday; and
there are concurrent sessions with the Australasian Society of Cosmetic Dermatologists and overlapping with
both the Australian Dermatology Nurses’ Association meeting and the meeting of the Australasian Society for
Dermatologic Research. This offers you a variety of choices.
2
I am particularly delighted to welcome our overseas speakers:
rofessor Marcus Maurer, Professor of Dermatology and Allergy and Director of Research at the
P
Department of Dermatology and Allergy, Allergie-Centrum-Charite, Universitatsmedizin, Berlin, Germany.
rofessor Albert C. Yan of the Children’s Hospital of Philadelphia and the Perelman School of Medicine at
P
the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
rofessor Amit G. Pandya from the Department of Dermatology at the University of Texas South-Western
P
Medical Centre in Dallas, Texas, United States of America.
r John G. Albertini, President of the American College of Mohs Surgery and the Wake Forest University
D
Department of Plastic and Reconstructive Surgery, Winston-Salem, North Carolina, United States of
America.
Sponsored speakers who will participate in sponsored sessions are:
r Jeremy B. Green, a cosmetic dermatologist who is an Assistant Professor in the University of Miami
D
Department of Dermatology, Miami, Florida, United States of America.
Dr Green’s participation is made possible by an unconditional grant to College by
rofessor Thomas Luger, Director and Chairman of the Department of Dermatology at the Westfalische
P
Wilhelms-Universitat in Munster, Germany.
Professor Luger’s participation is made possible by the generous support of
r Emil Tanghetti, a US Board-certified dermatologist specialising in laser medicine and surgery.
D
Dr Tanghetti’s participation is made possible by the generous support of
rofessor Eggert Stockfleth, Director of the Skin Cancer Centre, Charite–University Medical Centre, Berlin,
P
Germany.
Professor Stockfleth’s participation in the meeting is made possible by the generous support of
Overseas speakers in the program for the Australasian Society of Cosmetic Dermatologists are:
r Christoph Martschin, a senior consultant dermatologist in medical and aesthetic dermatology in
D
Sweden.
Dr Torsten Walker, a dermatologist from Germany whose practice has an aesthetic focus.
Dr Walker’s participation in the meeting is made possible by the generous support of
I am very pleased that the meeting has been strongly endorsed by the pharmaceutical and allied health
industries, both as sponsors and as trade exhibitors. I invite all delegates to visit the displays in the trade
exhibition, to meet the industry representatives and to learn about new developments in products and services.
The College and its members strongly rely on the support from our industry partners in ensuring that our
patients are offered optimal management with the latest advances in medical and surgical treatment.
The College meeting could not be successful without the generous sponsorship we receive from many
companies. I thank our sponsors, who are listed in this program, for their loyal support.
I hope you will find this meeting a most worthwhile and enjoyable experience.
THE AUSTRALASIAN COLLEGE OF DERMATOLOGISTS
A/Prof. Stephen Shumack, OAM, FACD, FAICD
48th ANNUAL SCIENTIFIC MEETING 2015
3
A/Prof. S. Shumack, OAM
A/Prof. C. Baker
A/Prof. G. Fischer
Dr P. Lowe
Dr J. Horton
Dr D. Cook
Dr M. Pitney
Dr A. Lewis
Dr A. Donnelly
Ms S. Doyle
President
President-Elect
Dean of Education
Honorary Secretary
Elected Director (VIC)/Chair, Audit Committee
Elected Director (NSW)
Elected Director (QLD)
Elected Director (SA)
Elected Director (WA)
Non-member Director
Chief Executive Officer
Mr T. Wills
New South Wales Faculty
Dr N.S. Agar
Prof. C. Anderson
Dr F.E. Anderson*
Dr R.P. Armati
Dr S. Arnold
Dr P. Artemi
Dr N. Aspres
Dr S. Bakis-Petsoglou
Dr M. Bannister
Emer. Prof. R.St.C. Barnetson
Dr L.D. Bear
Dr G. Becker
Dr P. Brown
Dr P. Bunce
Dr G.D. Cains
Dr L.J. Cains* (deceased
02/09/2014)
4
Dr J.C. Chapman
Dr P.G. Chee
Dr K. Chen
Dr J.Y.J. Choi
Dr E.Y.Y. Chow
Dr E. Christou
Dr R. Cocciolone
Cl. A/Prof. C.A. Commens
Dr D.K. Cook
Dr N. Cook
Prof. A.J. Cooper, OAM
Dr G. Cottee
Dr A.E. Cronin*
Dr K.A. Crotty
Prof. D.L. Damian
Dr D.E. Davies
Dr E. Dawes-Higgs
Dr J.W. de Launey
Dr W.E. de Launey
Dr R.W. Denisenko
Dr S. de Zwaan
Dr E. Doherty
Dr S. Donoghue
Dr C.J. Drummond
Dr K.J. Dunlop
Dr P.K. Dwyer
Dr K. Engeti
Dr H. Fallah
A/Prof. P. Fernandez-Peñas
Dr A.G. Finley, OBE* (deceased
14/10/2013)
A/Prof. G. Fischer
Dr J. Fisher
Dr B. Florance, RFD, RD*
Dr J. Foo*
Dr P.C. Frederiksen
Dr P.A. Freeman
Dr S. Freeman
Dr G. Frost
Prof. K. Georgouras, OAM
Dr D. Gillam
Dr R. Gillespie
Dr T.K. Gilmour
Dr G. Gottschalk
Dr E. Gow
Dr I. Grigoris
Dr K. Gudmundsen
Dr P. Guitera
Dr M. Gupta
Dr R. Gupta
Dr I.D. Hamann
Dr R.S. Hannaford
Dr R. Harvey
Dr M.F. Healsmith
Dr S. Heiman
Dr K.K-L. Ho
Dr P. Hogan
Dr D. Holt
Dr E. Hong
Dr R. Howes
Dr M.J. Hunt
Dr N.T. Huynh
Dr F. Isaacs
Dr N, Jang
Dr M. Jones-Caballero
Dr A.G. Jopp-McKay
Dr S. Kalouche
Dr C.R. Kearney
Dr S. Khurana
Dr J. Konya
A/Prof. S. Kossard
Dr J.F.C. Krivanek
Dr J.M. Kuchel
Dr A. Kumar
Dr A. Kurien
Dr A-M. Kurzydlo
Dr E. Lamrock
Dr W.A. Land, AM, RFD, AE
Dr M.M. Lane-Brown
Dr K.H. Le
Dr M-L. Lee
Dr M-S. Lee
Dr M. Lee
Dr P.A. Lee
Dr S.H. Lee
Cl. A/Prof. S. Lee, AM
Dr J.L. Le Guay
Dr M. Leibowitz
Dr L.J. Leow
Dr J. Lewis
Dr M. Li
Dr A. Lim
Dr P. Lim
Dr T.K. Lipscombe
Dr M. Llewellyn
Dr E. Lobel
Dr M.S. Loghdey
Dr P.M. Lowe
Dr M. Lowes
Dr J. Mackay
Dr A.R. Mackenzie-Wood
Dr L. Martin
Dr J. Matulich
Dr I.D. McCrossin
Dr R.R.A. McDonald
Dr S. McDonald
Dr B. McGaw*
Dr C. McKay
Dr M. McRae
Dr A.C. Miller
Dr A. Ming
A/Prof. F. Moloney
Dr C. Morrow
Dr A.St.L. Moss
Prof. D. Murrell
Dr S.Y. Ng
Dr R.T.D. Nguyen
Dr A. O’Neill
Dr C.S-C. Ong
Dr V. Paddon
Dr B.K-C. Pang
A/Prof. K. Parsi
Dr A. Patel
A/Prof. R.D. Paver
Dr R.D. Peek
Dr T.A. Phan
Dr T.S.C. Poon
Dr E. Pritchard
Dr V. Pua
Dr W. Regan, AM
Dr J.P. Relic
Emer. Prof. S.W. Richards
Dr C.A. Riordan
Dr J. Robinson
Dr M. Rogers
Dr R.H. Rosen
Dr D. Rubel
Dr W.J. Ryman
Dr R.M. Salmon
Dr A.C. Satchell
Dr C.A. Saywell
Dr L. Saywell
Dr A.C.Y. See
Dr J-A. See
Dr J.F. Shannon
A/Prof. S.P. Shumack, OAM
Dr S.E. Sinclair
Dr J.R.A. Sippe
Dr G. Sivapirabu
Dr S. Smith
Dr D.G. Stanford
Dr K.M. Stapleton
Dr E. Starritt
Dr A. Steele-Smith
Dr J. Steele-Smith*
Dr R.B.H. Stephens
Dr M. Stewart
Dr N. Stewart
Dr H.M. Studniberg
Dr J.R. Sullivan
Dr M.C. Symons
Dr M. Tam
Dr F.J. Tefany
Dr K.E. Thai
Dr C.H.F. Thoo
Dr A. Tomizawa
Dr A. Varol
Dr S. Venugopal
Dr S.Virdi
Dr M.S. Wade
Dr E. Waine
Dr B. Wallace
Dr R. Walther
A/Prof. O. Wargon, OAM
Dr R. Watchorn
Dr A.B. Watson
Dr G.C. Watt
Dr A. Wegman
Dr P.A. Weller
Dr J. Wells
Prof. W. Weninger
Dr L. Wheeler
Dr H.A.D. White, AM, RFD
Dr M. Whitfeld
Dr E. Willsteed
Dr N. Wines
Dr R. Wittal
Dr D.Y-S. Wong
Dr D.A. Wong
Dr K.C-W. Wong
Dr L-C.F. Wong
Dr G. Wood, AM
Dr J. Woods
Dr E. Yiasemides
Dr J. Yip
Dr I.R. Younger
Cl. A/Prof. S.S. Zagarella
5
Queensland Faculty
Dr C.D.Y. Adib
Dr M.L. Andrews
Dr J.C. Auld
Dr H. Avery
Dr S. Baghaei
Dr L. Banney
Prof. G.L. Beardmore
Dr K.E. Behne
Dr D. Burdon-Jones
Dr G.J. Butler
Dr J.L. Byth
Dr B. Carew
Dr T. Casey
Dr J.E.D. Chick
Dr K-Y. Choong
Dr D. Coates
Dr J.G. Coates
Dr N.J. Collins
Dr B-I. Cominos
Dr S. Congdon
Dr S.L. Conias
Dr T.A. Darben
Dr S. Davidson
Dr B.J. De’Ambrosis
Dr K. DeAmbrosis
Dr R.M. De Voss
Dr A.J. Dore
Dr C.F. Faulkner
Dr D.B. Francis
Dr M.G. Freeman
Dr Z.S. Gaspar
Dr R. Gild
Dr A.M. Godbolt
A/Prof. N. Haass
Dr M.W. Harley
Dr A. Herat
Dr R.J. Hills
Dr G.J. Holmes
Dr B. Jones
Dr L.J. Kelly*
A/Prof. K. Khostrotehrani
Dr Y.J. Kim
Dr S. Kumar
Dr Y.N. Lau
Dr C.T. Lee
Dr K-C. Lee
Dr Y. Lee
6
Dr D.F. Leslie
Dr D. Lim
Dr K.R. Lun
Dr S. Manoharan
Dr I. McColl
Dr P.L. McLaran
Dr E. McMeniman
Dr C.H. Mercer
Dr P.M. Millar
Dr R.MacD. Miller
Dr A.B. Mirza
Dr J.B. Muir
Dr A.J.D. Mulholland
Dr R.R. Noakes
Dr M.A. Oziemski
Dr S.M. Ozluer
Emer. Prof. J.A. Pagliaro
Dr C. Petherbridge*
Dr M.J. Pitney
Dr W.W. Pruim
Dr S. Reid
Dr I.M. Robertson
Dr K.H. Rodins
Dr C. Sander
Dr M.S. Saywell
Prof. H. Schaider
Dr M.P. Sharkey
Dr V.L. Shepherd
Dr G.M. Siller
Dr P.R. Sinclair
Dr R.J. Sinclair
Prof. H.P. Soyer
Dr L.J. Spelman
Dr G.J. Stephenson
Dr P. Teng
Dr S. Tritton
Dr S. Tucker
Dr F.J. van der Walt
Dr Y.Y. Vun
Dr G.H. Wagner
Dr S.D. Waite
Dr S. Webber
Dr J.W. Wells
Dr P.R. Wilson
Dr J.K-H. Wu
Dr S.A. Yong-Gee
Dr C. Yoong
Dr T. Zappala
South Australian Faculty
Dr S. Anabarasu
Dr P. Armenores
Dr S. Ball
Dr C. Black
Dr M. Black
Dr R.M. Czechowicz
Dr C.M. Duguid
Dr L. Gordon
Dr N.L. Grieve
Dr M.J.A. Hanna
Dr E. Haverhoek
Dr D.C. Hill
A/Prof. S.C. Huilgol
Dr J. Kirk
Dr K.J. Koh
Dr Y-C. Lee
Dr A.E. Lewis
Dr D. Long
Dr H. Ly
Dr R. Manifold
Dr G. Marshman
Dr J. Menz
Dr S.C. Murray
Dr K. Newland
Dr J. Nicolson
Dr V.F. O’Brien
Dr C.G-G. Ooi
Dr C.J. Parker
Dr A.L. Pearce
Dr C. Reid
Dr E. Ryan
Dr P.A. Selva-Nayagam
Dr K. Shirato
Dr S.K. Sidhu
Dr I.J. Simmons
Dr C.J. Tyson
Dr S. Vaidya
Dr P.C. Walker
Dr L.J. Warren
Dr J.A. Wayte
Dr W. Weightman
Dr J. Wesley
Dr T.P. Wiadrowski
Dr L.M. Wilson
Victorian Faculty
Dr A.N.R. Amerasinghe
Dr K. Armour
A/Prof. C.S. Baker
Dr J. Banky
Dr P.S. Bekhor
Dr P.A. Berger
Dr N.R. Bleasel
Dr T. Bohl
Dr A. Boyapati
Dr A. Boyce
Dr A. Braue
Dr B. Breadon
Dr J.A. Brenan*
Dr S.K. Brennand
Dr F.J. Bruce
Dr J.C. Burford
Dr J.M. Butler, AM
Dr J. Cahill
Dr A.W. Callan
Dr N.J. Callan
Dr J. Cargnello
Dr T. Carner
Dr A. Catona
Dr A.J. Chamberlain
Dr S. Chandra
Dr V. Chitreddy
Dr A.H.O. Chong
Dr A.C. Ciconte
Dr T.J. Connors
Dr P.S.J. Cowen
Dr R.B. Crouch
Dr P.A. Curnow
Dr D.B. Czarnecki (resigned
31/12/2014)
Dr R.L.S. Dickinson
Dr H. Dinh
Dr C. Dolianitis
Dr N.P. Downes
Dr R. Dunn
Dr D. Dyall-Smith
Dr S. Eisman
Dr B.R. Entwisle*
Dr P.E. Fergin
Dr E. Finkelstein
Dr A. Fitzgibbon
A/Prof. P.A. Foley
Dr D. Gan
Dr D.V. Gill
A/Prof. S. Gilmore
A/Prof. Dr D. Gin
Dr M.S.Y. Goh
A/Prof. G.J. Goodman
Dr J. Green
Dr C. Grills
Dr S. Gunatheesan
Dr S. Gupta
Dr L.R.S. Hale
A/Prof. A.P. Hall
Dr S.C. Harrison
Dr M.I. Haskett
Dr E. Hiscutt
Dr J. Horton
A/Prof. Dr A. Howard
Dr C. Jalilian
Dr W.J. Jamieson*
Dr A. Jevtic
Dr S. Joseph
Dr J.R. Kelly*
A/Prof. J.W. Kelly
Dr R.I. Kelly
Dr P.J. Lane
Dr D. Lanzer
Dr A. Lasocki
Dr A.Y.L. Lee
Dr M.W-K. Lee
Dr S-W. Lim
Dr W. Liu
Dr E. Ma
Dr A.W-Y. Mar
Dr V. Mar
Prof. R. Marks, AM
Dr D.M. McColl
Cl. A/Prof. C.J. McCormack
Dr O. McCurdy
Dr C. McDonald
Dr C.J. Meehan
Dr A.C. Michaelides
Dr M. Mohamed
Dr V.A. Morgan
Dr M.L.L. Moyle
Dr J. Ng
Dr J. Nicolopoulos
A/Prof. R. Nixon
Dr D.S. Nurse*
Dr T.J. O’Brien
Dr R.J. O’Keefe
Dr J.M. Opie
Dr D.C. Orchard
Dr M. Palmer
Dr Y. Pan
Dr A. Perez De Velasco
Dr E.C-H. Poon
Dr B. Rajagopalan
Dr D. Rathnayake
Dr G.J. Rennick
Dr M.V. Rich
Dr H. Roberts
Dr S. Robertson
Dr M.A. Rodrigues
Dr G.L. Ross
Dr H. Rotstein (deceased
26/09/2014)
Dr A. Rudd
Dr R. Ruiz Araujo
Dr T.J. Rutherford
Dr K. Sandhu
Dr A. Saracino
Dr H.L. Saunders
Dr L.V. Scardamaglia
Dr C.E. Scarff
Dr C. Schofield
Dr A.H. Segal
Dr M. Seith
Dr P. Sharma
Dr D.A.R. Shephard
Dr A. Sheridan
Dr N. Shim
Dr P.A. Sinclair
Prof. R.D. Sinclair
A/Prof. M.J. Sladden
Dr A. Stavrakoglou
A/Prof. J.C. Su
Dr E.H. Taft, AM*
Dr M.M. Tam
Dr B.T. Tan
Dr E. Tan
Dr B.J. Tate
Dr D. Tran
Dr A. Tuxen
Dr E.J.McK. Upjohn
Prof. G.A. Varigos
Dr F. Y-Y. Watkins
Dr M.R. Webster
Dr B.M. Welsh
Prof. I. Winship
Dr K. Wolfowitz
Dr L-M. Yap
Dr A. Yazdabadi
Dr J.M. Yeatman
Dr L. Yip
Dr L. Young
7
Western Australian Faculty
Dr J. Adamson
Dr J.H. Allison*
Dr K. Borchard
Dr R. Brand
Dr T. Caccetta
Dr J.J.S-M. Chan
Dr P. Cherian
Dr H.C. Chua
Dr C. Clay
Dr J. Cole
Dr B.L. Connor
Dr K.J. Dallimore
Dr T.A. Delaney
Dr A.M. Donnelly
Dr T.G. Elliott
Dr R. Foster
Dr G. Foxton
Dr H. Gebauer
Cl. A/Prof. K. Gebauer
Dr R. Granger
Dr A.R. Halbert
Dr W.K. Hedley
Dr D. Hewitt
Dr P. Kumarasinghe
Dr G. Masel
Dr W.B. Muston*
Dr K.M. Opie
Dr L.M. Pepall
Dr C.J. Quirk
Dr P.L. Randell
Dr B. Ricciardo
Dr J.B. Rohr
Dr G.M. Sadler
Dr D. Singh
Dr G.D. Singh
Dr P. Singh
Dr T.M. Skender-Kalnenas
Dr H. Smith
Dr P.T. Swarbrick
Dr Y.J. Tai
Dr C.P. Tait
Dr E.B.C. Tan
Dr G.A. Thom
Dr E. Veysey
Cl. A/Prof. C. Vinciullo
Dr J.A. von Nida
Dr L.M. Wall
Dr S. Weston
Resident in New Zealand
Dr J.D. Adams
Dr L.M. Armstrong* (SA Faculty)
Dr W.J. Burton (NSW Faculty)
Dr T. Gunson (WA Faculty)
Dr M. Heng
Dr M.W. Hursthouse (SA Faculty)
Dr D. Rowan (SA Faculty)
Dr P.J. Sears
Dr B.C. Turnbull* (SA Faculty)
Dr D.W. Young (VIC Faculty)
* Foundation Members
Prof. E. Tschachler – Austria
Prof. C.R. Blackburn, AC - New
South Wales
Dr P. Bullpitt – New South Wales
Dr K.C. Chong – Queensland
Dr E.C. Cleary – South Australia
Dr R. Crouch – New South Wales
Dr A. Darling - Victoria
Dr A.P. Dorevitch - Victoria
Dr J.P. Dowling - Victoria
Dr R.E.T. Duhig – Queensland
Dr B. Dutta – New South Wales
Dr R.B. Dymock - South Australia
A/Prof. D. Ellis - South Australia
Dr J. Farnsworth - Queensland
Dr A. Fischer – New South Wales
8
Dr D.S. Forbes - New South Wales
Dr J. Fryer - New South Wales
Cl. Prof. C.L. Goh - Singapore
Dr A. Gramp - South Australia
Dr W.A.D. Griffiths - United Kingdom
Prof. G. Halliday - New South Wales
Dr P.J. Heenan - Western Australia
Dr V.C. Howard – New South Wales
Dr C. James – South Australia
Dr B. Kynaston – Queensland
Dr J. Magee – Victoria
Dr S. Mann – New South Wales
Dr G. Mason - Victoria
Miss R. McAleer, AM - Western
Australia
Prof. S. Menzies – New South Wales
Dr D. Muir - New South Wales
Prof. H.K. Muller - Tasmania
Prof. R. Penny, AO - New South
Wales
Prof. H.M. Prince - Victoria
Dr A. Ryan - Victoria
Dr G. Strutton - Queensland
Dr J. Sullivan – Queensland
Dr S. Swain - Victoria
Dr J. Tversky - Victoria
Prof. D. Weedon, AO - Queensland
Dr R.A. Williams - Victoria
Prof. K. Wolff – Austria
Cl. A/Prof. L. Yu – Western Australia
PR OGRAM
The scientific sessions of the meeting will be held in Hall L of the Adelaide Convention Centre. Concurrent
sessions will be held in Hall M.
The following satellite meetings are being held in association with the College conference:
Australasian Society for Dermatology Research
Stamford Plaza Adelaide Hotel
Friday 15 May and Saturday 16 May 2015
ustralian Dermatology Nurses’ Association 14th Annual National
A
Conference
Hall N, Adelaide Convention Centre
Saturday 16 May and Sunday 17 May 2015
ustralasian Society of Cosmetic Dermatologists 2nd Aunnual Meeting
A
Hall N, Adelaide Convention Centre
Monday 18 May and Tuesday 19 May 2015
The registration desk is located in Foyer M. The registration desk will open on Saturday 16 May from 0700 and
will be open throughout the meeting.
The conference organiser’s office and secretariat are in Room L1b (off Foyer L and behind the speakers’
preparation room).
College has a stand (No.1) in the trade exhibition, manned by members of the College staff.
Come and meet the staff and find out what we can do for you. Pick up some leaflets and other freebies; find
out about the website; check your CPD.
We are located just to the left, after you enter the main entrance of the exhibition.
The ID tags are recyclable, so delegates are asked to return these at the end of the meeting.
ID tags must be worn at all times. Delegates without ID may be refused entry to sessions and to the trade
exhibition.
9
Please assist exhibitors by using the bar code on your ID
tag to identify yourself to them.
The speakers’ preparation room is located in Room
L1a of the Adelaide Convention Centre (next to the
organiser’s office). The room is staffed daily. The
technician will be on hand one hour before the start
of each session, then 30 minutes after close of the
final session. Presenters are encouraged to hand their
presentations in at least two hours before required
onstage, or the day before if presenting early in the
morning.
The trade exhibition is in Hall H. It will be open on the
following days:
unday 17 May from 1000 to 1600
S
(1245 official opening)
Monday 18 May from 1000 to 1600
Tuesday 19 May from 1000 to 1400
Morning tea, lunch and afternoon tea will be served in
the trade exhibition, on Sunday, Monday and Tuesday.
If there are papers of sufficient merit, the following
awards/prizes will be awarded:
The morning and afternoon tea breaks will be for half an
hour. The lunch break will normally be one hour, except
on Monday 18 May and Tuesday 19 May 2015 when it
will be longer.
est research paper read at the Annual Scientific
B
Meeting - F. & E. Bauer Foundation Prize
Best paper in the Registrars’ Forum
All delegates will receive a trade passport: collect 24
stamps from exhibitors in your passport and you can go
into a lucky draw for valuable prizes.
est poster presentations (two prizes). Kindly
B
sponsored by the ASM Platinum Sponsor,
HOW TO
WIN
est paper or poster presentation by a New South
B
Wales Registrar, the Eileen Collins Memorial Prize –
funded by the New South Wales Faculty
WHEN CO
MPLETED
the details
box
N
D
CO
SE
VISA 1
VISA 2
E
IZ
PR
SIMPLY FIL
L THE DE
TAILS
OUT ON
THE BACK
est paper in Contact Dermatitis, the John Fewings
B
Memorial Prize - funded by the Skin and Cancer
Foundation Victoria
VISA 3
VISA 4
VISA 5
VISA 6
VISA 7
VISA 8
VISA 9
VISA 10
VISA 11
VISA 12
RD
HI ZE
VISA 13
T RI
P
VISA 14
VISA 15
VISA 16
VISA 17
VISA 18
VISA 19
Awards for outstanding exhibits
VISA 20
VISA 21
VISA 22
VISA 23
VISA 24
Awards for the outstanding exhibits will be announced on
Tuesday 19 May 2015. The categories of award are:
ost outstanding display of
M
9 sqm or less in size
M
18 sqm up to 27 sqm in size
M
36 sqm in size, or larger
The awards will be decided by a
panel of three judges.
College is offering a free downloadable web-based app
for the Annual Scientific Meeting. It includes information
about the scientific program, social program, etc. It will
also be used for responder sessions during the meeting.
The app can be used on most iPhones, notebooks and
laptops.
To download the app, go to http://eventmobi.com/
acdasm2015/
Note
The scientific program for the meeting has been
prepared by Dr Karen Koh, FACD, Dr Priya SelvaNayagam, FACD and Dr Sachin Vaidya, FACD, who
have been supported by the Honorary Secretary of
College and the College’s Scientific Meetings Steering
Committee which in turn reports to the Board of
Directors.
The topics and speakers for all sponsored symposia
and breakfast sessions have been approved by the
College.
10
UPPER LEVEL
WEST
CENTRAL
EAST
FOYER A
FOYER B
STAIR
PANORAMA
BALLROOM
PANORAMA
FOYER
A
SKYWAY
LIFT
P1 P2
B
LIFT
P3
ESCALATOR
STAIR &
ESCALATOR
PANORAMA
ROOMS
SKYWAY
FOYER
S1
LIFT
ESCALATOR
S2
S3
CITY
SUITE
FOYER
CS1
CS2
PROPOSED
STAGE 2
DEVELOPMENT
SKYWAY
ROOMS
STAIR
CITY
SUITES
CS3
CS4
CITY
ROOMS
CITY
FOYER
1
C1 C2 C3 C4
CITY
FOYER
2
CITY
CITY
FOYER FOYER 4
3
CITY
TERRACE
GROUND LEVEL
WEST
CENTRAL
EAST
FESTIVAL DRIVE
RIVERBANK
CAR PARK
PANORAMA
SUITE
LIFT
FOYER E
STAIR
STAIR
FOYER F
FOYER
L2
FOYER
L3
LIFT
OFFICE F
MONTEFIORE ROAD
L1a
WESTERN
ENTRANCE
STAIR
L1b L2
L3
F
STAIR &
ESCALATOR
G
C
RECEPTION
FOYER G
LINK
OFFICE
H
H
N
FOYER H
O
MAIN
ENTRANCE
OFFICE K
I
NORTH
TERRACE
CAR PARK
J
K
PLAZA
ACCESS
RAMP
LIFT
LOADING
DOCK
D
PROPOSED
STAGE 2
DEVELOPMENT
ATRIUM
ENTRANCE
M
LIFT
E3
ATRIUM
FOYER
LIFT
STAIR
E2
ESCALATOR
L
FOYER M
E1
LIFT
LIFT
FOYER L
ESCALATOR
RIVERBANK
CAR PARK
STAIR
HOTEL INTERCONTINENTAL
FOYER
L1
ATRIUM
ENTRANCE
ESCALATOR
NORTH TERRACE
LOWER LEVEL
WEST
CENTRAL
RIVERBANK
OFFICE
FOYER
R4
STAIR
FOYER
R8
FOYER
R7
R8
R8b
FOYER
R5
FOYER
R6
LIFT
R4
R7
R6b
RIVERBANK
BOARD ROOM
FOYER FOYER
R3
R2
R3
R2
R6
R1
FOYER
R1
STAIR
R5
REGATTAS
BISTRO
LIFT
RIVERBANK
ROOMS
11
27/02/2014
Saturday 16 May 2015
0700-1700
Registration of delegates and Associates, Foyer M
Hall L
Hall M
Hall N
0730-0830
0845-1300
0900-1630
ACD ASM:
Registrars’
Training Day
1000-1700
1030-1100
1230-1330
1300-1400
1400-1530
1430-1500
1530-1600
1600-1730
1900-2400
12
ACD ASM:
Morning tea in
Foyer L
Lunch in Foyer L
ACD ASM:
ACD ASM:
Registrars’ Forum
Psoriasis
Symposium
Afternoon tea in Foyer L
ACD ASM: La
Roche Posay
Sponsored
Symposium:
Targeting the
Human Skin
Microbiome in
Patients with
Atopic Dermatitis
ADNA Meeting:
Plenary Sessions
ADNA Meeting:
Morning tea in
Foyer N
ADNA Meeting:
Lunch in Foyer N
City Rooms 1, 2, Riverbank Room Riverbank Rooms Hall L
3 and 4
5
6, 7 and 8
Foyer
ACD ASM:
Menarini
Sponsored
Breakfast: A
Masterclass
with Prof. Eggert
Stockfleth:
Evidence-Based
Management
of Field
Cancerisation
Panorama
Ballroom
ACD ASM: Mohs
Surgery Peer
Review Session
and Business
Meeting
ADNA Meeting:
Afternoon tea in
Foyer N
ACD ASM:
Conference
Dinner
Sunday 17 May 2015
0700-1700
Hall L
Hall M
Hall N
0730-0830
0845-0850
0850-1045
0930-1505
1200-1300
1045-1115
1115-1245
1200-1300
Opening of Trade Exhibition and Lunch, Hall H
ACD ASM: Contact ACD ASM: Laser
Dermatitis
Symposium
1830-1930
1930-2000
Panorama
Ballroom
ADNA Meeting:
Plenary Sessions
ADNA Meeting:
Morning tea in
Trade Exhibition,
Hall H
ACD ASM: Morning tea in Trade Exhibition, Hall H
ACD ASM:
ACD ASM:
Paediatric
Melanoma
Dermatology
Symposium
Symposium
ADNA Meeting:
Lunch in Trade
Exhibition, Hall H
1345-1515
1515-1545
1545-1715
Riverbank Rooms Hall L
6, 7 and 8
Foyer
ACD ASM:
Novartis
Sponsored
Breakfast: A
New Era for
the Psoriasis
Patients: IL-17
Inhibition
ACD ASM: Official
Opening by A/
Prof. S. Shumack,
OAM, President,
Australasian
College of
Dermatologists
ACD ASM:
Plenary Session 1
1245-1345
1505-
City Rooms 1, 2, Riverbank Room
3 and 4
5
ACD ASM:
Janssen
Sponsored
Breakfast:
Treating the
Full Spectrum:
Unmet Needs in
Psoriasis
ADNA Meeting:
Afternoon tea in
Trade Exhibition,
Hall H
Afternoon tea in Trade Exhibition, Hall H
ACD ASM:
ACD ASM:
Pigmentary
Non-Melanoma
Diseases
Skin Cancer
Symposium
Symposium
ACD Graduation
Oration and
Conferring of
Diplomas and
Awards
Drinks for
Graduands and
Families
13
Monday 18 May 2015
0700-1700
Hall L
Hall M
Hall N
0730-0830
0845-1030
1000-1045
1030-1100
1045-1130
1100-1230
1130-1200
1200-1300
1230-1400
1300-1400
1400-1500
1430-1530
1500-1530
1530-1700
1700-1800
1700-1830
1830-2000
14
ACD ASM:
Plenary Session 2
ASCD Meeting:
Session 1:
How to Start
a Cosmetic
Practice and How
to Approach a
Cosmetic Patient
Morning tea in Trade Exhibition, Hall H
ASCD Meeting:
Session 2:
Approach to
the Patient:
Understanding
and Assessment
of the Cosmetic
Patient
ACD ASM: Virtual
Clinical Meeting
ASCD Meeting:
Session 3:
Anatomy of the
Face and Neck:
Facial Anatomy
for Injections
and Field
Blocks, Local
Anaesthesia and
Danger Areas
ASCD Meeting:
Session 4:
Lasers – How to
Introduce to your
practice
Lunch in Trade Exhibition, Hall H
Lunch in Trade
Exhibition, Hall H
ACD ASM: Genital ACD ASM: Free
Dermatology
Papers Session
Symposium
ASCD Meeting:
Session 6: Speed
Dating and
Afternoon Tea
with Trade, Hall H
Afternoon Tea in Trade Exhibition, Hall H
ACD Annual
Registrars’
General Meeting Teaching Session
ACD ASM:
Cynosure
Sponsored
Symposium:
The Latest
Advancements
in Aesthetic
Picosecond
Technologies
ACD ASM:
ASCD Meeting:
Celgene
Session 7:
Sponsored
Injecting Dummy
Symposium:
Session
Understanding
Unmet Needs
in Psoriasis,
Psoriatic
Arthritis and
Small Molecule
Oral Treatment
Options
Genie Meeting
City Rooms 1, 2, Riverbank Room
3 and 4
5
ACD ASM:
Lilly Australia
Sponsored
Breakfast: The
Great Debate:
Goals of
Treatment for
Severe Psoriasis
– do we need to
redfine them?
Riverbank Rooms Hall L
6, 7 and 8
Foyer
ACD ASM
Leo Pharma
Sponsored
Breakfast:
Optimising
Patient Outcomes
with Picato®
Gel: How far can
it go?
Panorama
Ballroom
Tuesday 19 May 2015
0700-1600
Hall L
Hall M
Hall N
0730-0830
0845-0945
0845-1015
0945-1030
1015-1045
ACD ASM: Global ACD ASM: All
About Acne:
Dermatology
Eruptions on
Symposium
the Acne Front
– Controversies
and Challenges
1100-1215
1200-1330
1215-1300
ACD ASM: What’s
Caught my Eye
1330-1400
1345-1445
1400-1445
1445-1500
1445-1530
1530-1600
1600-1700
Panorama
Ballroom
ASCD Meeting:
Session 9: Fillers
Morning Tea in
Trade Exhibition,
Hall H
ASCD Meeting:
Session 9: Fillers
(continued)
Lunch in the Trade Exhibition, Hall H
1300-1330
1330-1345
Riverbank Room Riverbank Rooms Hall L
5
6, 7 and 8
Foyer
ACD ASM: Cutera
Australia Pty
Ltd Sponsored
Breakfast:
The Laser
Dermatology
Experience using
Pico, Nano and
Milli Second
Technology in
Conjunction
with 532nm
and 1064nm
wavelengths
Morning Tea in the Trade Exhibition, Hall H
1030-1100
1045-1200
ASCD Meeting:
Session 8:
Introduction to
Skin Care and
Skin Care Panel
City Rooms 1, 2,
3 and 4
ACD ASM:
Galderma
Sponsored
Breakfast:
From Lamp to
Light: How to
Perform Daylight
Activated PDT
ACD ASM:
Continuing
Professional
Development
ACD ASM: Plenary
Session 3
ACD ASM:
Presentation
of Awards and
Closing Remarks
ASCD Meeting:
Session 10:
Botulinum Toxin
ASCD Annual
General Meeting
Lunch in Trade
Exhibition, Hall H
ASCD Meeting:
Session 10:
Botulinum Toxin
(continued)
ASCD Meeting
Session 11:
Lasers
Afternoon Tea in
Foyer N
ASCD Meeting:
Session 12:
Debates
15
T H E A U S T R A L A S I A N C O L L E G E O F D E R M AT O L O G I S T S 4 8 T H A N N U A L S C I E N T I F I C M E E T I N G
0700-1700REGISTRATION of delegates and
associates, Foyer M
0730-0830MENARINI SPONSORED BREAKFAST:
A MASTERCLASS WITH PROF.
EGGERT STOCKFLETH: EVIDENCEBASED MANAGEMENT OF FIELD
CANCERISATION
City Rooms 1, 2, 3 and 4
Speaker: Prof. Eggert Stockfleth
0830
END OF SESSION
1400-1530CONCURRENT
SYMPOSIUM
1A: PSORIASIS
SYMPOSIUM
Hall L
Chair: Dr S. Sidhu
1400A/Prof. P. Foley
Update on
biologics including
biosimilars
1420Dr S. Cameron
The value of
QFN gold in
pre-screening
assessments for
non-biologic
immunosuppressive
agents
1440Dr E. Pontifex
Psoriatic
arthropathy
assessment for the
dermatologist
1500Panel discussion
Presentation of
challenging case
studies
1530END OF SESSION
CONCURRENT SESSION 1
0845-1300REGISTRARS’ TRAINING SESSION
Hall L
Convenor: Dr K. Koh
0845A/Prof. G. Fischer/Dr D. Stanford/
Dr A. Lim
Education update
0915A/Prof. S. Zagarella/Dr K. Chen
Evidence-based medicine – basic
principles
MORNING TEA IN FOYER L
1100Dr A. Sheridan
Mohs surgery – what registrars need to
know
1115Dr M. Gupta/Dr M. Andrews
Methotrexate and psoriasis
1130Dr L. Warren
When things REALLY go wrong
1200Dr R. Waddell
Syphilis in 2015
1230Dr D. Yeung
A haematologist’s perspective
1255Questions
1300
END OF SESSION
1300-1400
LUNCH IN FOYER L
1400-1530CONCURRENT SYMPOSIUM 1B: REGISTRARS’ FORUM
Hall M
Chair: Dr K. Koh
1400Dr M. Cicchiello
Assessment of delays to diagnosis of nodular melanoma
compared to superficial spreading melanoma
1408Dr A. Ingham
Multiple Orf lesions in an immunocompetent patient
treated successfully with imiquimod
1416Dr M. Abikhair
The off-label use of infliximab in dermatology: A review of
22 cases
1424Dr L. Byrom
Telederm National: A decade of teledermatology
1432Dr C. Kalai
Kimura’s disease arising from prurigo nodularis
1440Dr B. Kim
Scar outcomes in dermatologic surgery
1448Dr P. Sobarun
Localised IgG4-related skin disease, a rare clinical entitiy
1456Dr C. Wong
Think UV, not heat!
1504Dr P. Chen
Illness perception in association with psychological
functioning in patients with discoid lupus erythematosus
1512Dr B. Swan
Pulsed dye laser treatment at 2 weekly compared to 3
monthly intervals in infants with capillary malformations
1520Dr R. Saunderson
Perianal ulceration misdiagnosed as pyoderma
gangrenosum
1528Questions
1530END OF SESSION
1530-1600AFTERNOON TEA IN FOYER L
16
1030
1600-1730LA ROCHE-POSAY SPONSORED
SYMPOSIUM: TARGETING THE
HUMAN SKIN MICROBIOME IN
PATIENTS WITH ATOPIC DERMATITIS
Hall L
Speaker: Prof. T. Luger
In patients with atopic dermatitis, a
marked change in the skin micrbiome
diversity has been shown as a function
of the disease severity. Exploration of
the skin microbiome enables entirely
new approaches for the treatment
of infectious and inflammatory skin
diseases.
1730
END OF SESSION
1000-1700MOHS PEER REVIEW SESSION AND
BUSINESS MEETING
Riverbank Room 5
Convenor: Dr T. Wiadrowski
and A/Prof. S. Huilgol
1000
Mohs Peer Review Session
Defect reconstruction
Masters panel: A/Prof. J. Albertini
A/Prof. S. Huilgol
A/Prof. C. Vinciullo
1030MORNING TEA IN RIVERBANK ROOM
5 FOYER
1100Dr J. Albertini
Up top to down under: Forehead to
nose, and other 2 stage flaps
1200-1300LUNCH IN RIVERBANK ROOM 5 FOYER
1300-1400
Perioperative issues
Dr J. Albertini
A dermatologist’s perspective
Dr M. Warner
A microbiologist’s perspective
TBA
A haematologist’s perspective
1400-1430Dr E. Yiasemides/Dr C. James
QAP
1430-1500Dr R. Rosen
MBS Schedule updates
1500-1530
General session
1530-1630
Mohs Group Business Meeting
1630
Mohs Meeting Cocktail Party
1700
END OF SESSION
All Fellows are welcome to attend the Mohs Meeting.
1900-2400CONFERENCE DINNER
Panorama Ballroom, ACC
Music by the well-known Adelaide jazz
band, Black Fedora
17
AUST R ALI AN D E R M ATO LO GY N U R SE S’
ASSOC I AT I ON 1 4T H A N N UA L N AT IO N A L
CONFER ENCE
The scientific sessions of the meeting are in Hall N.
0800-1700REGISTRATION of delegates and
associates, Foyer M.
0845-1630
PLENARY SESSIONS
0845Sharon Temby, President, ADNA
and A/Prof. S. Shumack, President, ACD
Welcome and housekeeping
0900Keynote Speaker: RN S. Lawton, OBE
My dermatology journey from RN to OBE
1000Dr B. De’Ambrosis
PNI and other nasties
1030-1100MORNING TEA AND NETWORKING IN
FOYER N
1100Dr K. Newland
Cutaneous lymphoma
1130Dr Y-C. Lee
Female hair loss disorders
1200
State Education Day brainstorming
1230–1330LUNCH AND NETWORKING IN FOYER N
1330P. Faga, RN
Anaphylaxis
1400
Annual General Meeting
1430-1500AFTERNOON TEA AND NETWORKING IN
FOYER N
1500Dr P. Artemi
Surgical treatment of vitiligo
1530E. Senior, RN
Wound care case discussions
1600Dr E. Ryan
Psychodermatology
1630
END OF SESSIONS
CPD points for Saturday: 5.5
Social Program
EveningEgo Nurses’ Dinner: Farewell to Dennis
McCarter
National Wine Centre
Corner Botanic Road and Hackney Road,
Adelaide
(ADNA members only, numbers limited)
18
0730-0830JANSSEN SPONSORED
BREAKFAST: TREATING THE FULL
SPECTRUM: UNMET NEEDS IN
PSORIASIS
Chair: Dr W. Weightman
Speaker: Dr M. Rischmueller
0830
END OF SESSION
0845-0850OFFICIAL OPENING BY A/PROF.
S. SHUMACK, OAM, PRESIDENT,
AUSTRALASIAN COLLEGE OF
DERMATOLOGISTS
BREAKFAST SESSIONS
BREAKFAST SESSIONS
Sunday 17 May 2015
0730-0830NOVARTIS SPONSORED
BREAKFAST: A NEW ERA FOR
PSORIASIS PATIENTS: IL-17
INHIBITION
Riverbank Rooms 6, 7 and 8
Chair: A/Prof. P. Foley
Welcome and introduction
0735Dr L. Spelman
IL-17 inhibition – the evidence
0755Dr J. Sullivan
IL-17 inhibition – the patient
0815
Q &A Panel Discussion
0830
END OF SESSION
0915Prof. A. Pandya
Melasma: Differential diagnosis and
pathogenesis
0940Prof. A. Yan
Preadolescent acne: The argument for
early treatment
1005Prof. J. Albertini
Surgical pearls
1030Questions
1045
END OF SESSION
0850-1045PLENARY SESSION 1
Hall L
Chair: A/Prof. S. Shumack, OAM
0850Prof. M. Maurer
Problems and solutions in the
management of chronic urticaria
1115-1245CONCURRENT
SESSION 2A:
MELANOMA
SYMPOSIUM
Hall L
Chair: Dr C. Reid
1115Dr G. Carlos
Reflectance confocal
microscopy as a
diagnostic aid in
determined invasion in
lentigo maligna clinical
presentations
1135A/Prof. P. FernandezPenas
Topical and
intralesional therapies
for loco-regional
metastasis of cutaneous
melanoma
1145A/Prof. N. Haass
Making stressed
melanoma self-destruct
1155Dr K. Crotty
Be aware of the
BAPoma
1215Dr M. Brown
Adjuvant treatment of
melanoma
1235Questions
1245
END OF SESSION
1045-1115MORNING TEA IN TRADE EXHIBITION,
HALL H
1115-1245CONCURRENT SESSION 2B: PAEDIATRIC
DERMATOLOGY SYMPOSIUM
Hall M
Chair: Dr L. Warren
1115Dr C. Barnett
An update on genetic testing for the
dermatologist
1145Dr G. Harvey
Genetics of a rare entity
1153Dr J. Kern
Bullous pemphigoid in infants –
characteristics, diagnosis and treatment
1201Dr C. Chaptini
Prevalence of methicillin-resistant
Staphylococcus aureus in children with atopic
dermatitis: A longitudinal study
1209Dr S. Smith
Assessment of pharmacists’ knowledge
of the use of topical corticosteroids in
atopic dermatitis: Pre and post continuing
professional development education
1217Dr E. Mooney
Adverse effects of topical corticosteroids in
paediatric eczema: Australasian consensus
statement
1227Dr S. Strathie Page
SCALP syndrome: A rare clinical entity
1235Dr C. Zhao
Neonatal autoimmune blistering disease:
A systematic review of the literature
1245
END OF SESSION
19
1345-1515CONCURRENT SESSION 3B: CONTACT
DERMATITIS SYMPOSIUM
Hall L
Chair: Dr L. Gordon
1345A/Prof. R. Nixon
Occupational hand dermatitis in Victoria:
Causes and contributing factors
1405Dr C. Higgins
Occupational contact dermatitis among
healthcare workers: A retrospective review
1420Dr A. Lalji
The European nickel legislation – should
Australia follow?
1435Dr R. Meani
An unusual reaction following allergic
contact to grevillea Robyn Gordon
1442Dr P. Tong
Allergic contact dermatitis: Can your
moisturiser be the culprit?
1450Dr L. Gordon
Allergic contact dermatitis: Yes, it was the
clothes washing
1457Dr L. Gordon
Methylisothiazolinone – the story continues…
1515
END OF SESSION
1245-1345OPENING OF TRADE EXHIBITION AND LUNCH, HALL H
1345-1515CONCURRENT SESSION
3B: LASER SYMPOSIUM
Hall M
Chair: Dr K. Koh
1345Dr D. Lim
High density 1927 thulium
laser for actinic keratoses
– is this the ideal field
treatment?
1405Dr C. Robb
A novel hybrid ablative
and non-ablative
fractional resurfacing
treatment for clinical
efficacy with enhanced
patient experience
1425Dr M. Rodrigues
Medication-induced
pigmentation: A novel
treatment for an age-old
problem
1445Dr E. Tanghetti
Picosecond lasers
1505Questions
1515
END OF SESSION
20
1545-1715CONCURRENT SESSION 4A:
NON-MELANOMA SKIN CANCER
SYMPOSIUM
Hall L
1545Dr R. Carroll
Immune phenotype and
function: Management of
immunosuppression in high risk
SCC in renal transplant recipients
1610Dr J. Albertini
Non-melanoma skin cancer –
lessons I have learned
1630Dr M. Cho
Scalp basal cell carcinoma: A
review of 2202 cases
1645Dr A. Gupta
Management of squamous cell and
basal cell carcinomas of the head
and neck with perineural invasion
1700Dr J. Ma
In-transit squamous cell
carcinomas: An Australian case
series
1715
END OF SESSION
1515-1545AFTERNOON TEA IN TRADE EXHIBITION, HALL H
1545-1715CONCURRENT SESSION
4B: PIGMENTARY DISEASES
SYMPOSIUM
Hall M
Chair: Dr S. Vaidya
1545Dr S. Vaishampayan
Common and uncommon
dermatoses in darker skin
1600Dr M. Rodrigues
Vitiligo: An approach to treatment
1612Dr P. Artemi
New surgical treatments for vitiligo
1624Dr S. Vaidya
Approach to hypopigmentation or
depigmentation in children
1632Prof. A. Pandya
Management of post inflammatory
hyperpigmentation
1652Dr A. Lim
Laser treatments in patients of darker
skin types
1707Questions
1715
END OF SESSION
1830-1930GRADUATION
ORATION AND
CONFERRING OF
DIPLOMAS AND
AWARDS, HALL L,
ACC
Academic Procession
The audience is
requested to stand
when the academic
procession enters
the hall; and to
remain standing for
the playing of the
National Anthems of
Australia and New
Zealand.
Opening
Proceedings
A/Prof. Stephen
Shumack, OAM,
FACD, FAICD,
President of the
Australasian College
of Dermatologists,
will declare the
proceedings open
and address the
assembly.
Silver Medal
A/Prof. A. Howard
Dr W. Weightman
Certificate of
Meritorious Service
Dr H. Rotstein
(posthumous)
Prof. G. Varigos
Honorary Fellow
Prof. E. Tschachler
Mervyn Gold, OAM, Award
Dr R. Peek
Graduate from the ACD
Mohs Micrographic Surgery
Training Program
Dr C-Y. Lin
Fellows elected under
Clause 3.2 of the College
Constitution
Dr A.N.R. Amerasinghe
Dr Y.N. Lau
Dr M.S. Loghdey
Dr E. Tan
Dr D. Rathnayake
Prof. H. Schaider
Induction of New Fellows
Dr P. Armenores
Dr S. Arnold
Dr A. Boyapati
Dr P. Bunce
Dr B. Carew
Dr E. Christou
Dr K. DeAmbrosis
Dr S. Donoghue
Dr R. Gild
Dr E. Hong
Dr C. Jalilian
Dr E. Lamrock
Dr S. McDonald
Dr M. McRae
Dr M. Palmer
Dr D. Singh
Dr N. Stewart
Dr A. Tomizawa
Dr S. Virdi
Australasian College of
Dermatologists
Travelling Fellowship from
2014 Examinations
Dr A. Boyapati
ounders’ Medal for Procedural
F
Dermatology for 2014
Dr A. Boyapati
Ken Paver Medal for Medical
Dermatology For 2014
Dr A. Boyapati
President’s Medal for
Pharmacology for 2014
Dr P. Tong
Adrian Johnson Memorial Prize
for 2014
Dr D. Sebaratnam for his
publication “Laser and laser like
devices Part 2” in the Australasian
Journal of Dermatology
Eileen Collins Memorial Award
for 2014
Dr D. Sebaratnam for his
presentation “A cost comparison
of Mohs surgery and traditional
excision for basal cell carcinoma
in Australia”
Oath of Ethics
The new Fellows will affirm the
Oath of Ethics.
John Reid Oration
To be given by Dr Peter
Goldsworthy, AM, Australian writer
and medical practitioner.
Conclusion
The assembly is requested to stand
as the academic procession leaves
the auditorium.
Music
The Festival Statesmen
Light refreshments will be
available for graduands and
their guests following the
ceremony in the Foyer.
AUS T R ALI AN D E R M ATO LO GY N U R SE S’ A S S O CI ATI O N 1 4 TH A N N UA L N ATI O N A L C O N F E R E N C E
The scientific sessions of the meeting are in Hall N.
Sunday 17 May 2015
0730-0830JANSSEN SPONSORED BREAKFAST:
TREATING THE FULL SPECTRUM:
UNMET NEEDS IN PSORIASIS
Speaker: Dr M. Rischmueller
CPD issued separately by Janssen-Cilag
Pty Ltd
0830
END OF SESSION
0930-1505 PLENARY SESSIONS
0900Dr P. Artemi
Scar wars – pharmaceutical versus
cosmeceutical
0930S. Turner, RN – BDNG Ego Fellowship
Awardee
Xeroderma pigmentosum
1000A/Prof. P. Fernandez-Penas
How light is used in dermatology
1030-1100MORNING TEA IN ACD TRADE
EXHIBITION, HALL H
1100Dr S. Eisman
Pigmented lesions
1130A. Palmer, RN
Contact Allergen Bank
1200-1300LUNCH IN ACD TRADE EXHIBITION,
HALL H
1300G. Savoulian, RN
Treatment for chronic eczema from a
nurse’s perspective
1330Dr A. Rudd
Skin care: Preparing the canvas
1400Dr G. Marshman
Dermatologic challenges in West Timor
1430S. Temby, RN
CPD requirements and how to present for
auditing
1500S. Temby, President, ADNA
Close of conference
1505-AFTERNOON TEA IN ACD TRADE
EXHIBITION, HALL H
PD points for Sunday: 4.5
C
Total CPD points allocated: 10
21
Hall L
Chair: Dr J. Menz
0845Prof. M. Maurer
Chronic pruritus – what’s new in the
aetiology, diagnostic work up and
treatment?
0915Prof. A. Pandya
Management of melasma
0945Prof. M. Maurer
Innate immunity and autoinflammation
– what do we need to know as
dermatologists?
1015Questions
1030
END OF SESSION
22
1400-1500CONCURRENT SESSION 5A:
GENITAL DERMATOLOGY
SYMPOSIUM
Hall L
Chair: Dr P. Selva-Nayagam
1400A/Prof. G. Fischer
Long term management of
adult vulval lichen sclerosus: A
prospective cohort study of 507
women
1415Dr A. Lee
Pre-pubertal onset vulval lichen
sclerosus: The importance of
maintenance therapy in long-term
outcomes
1425Dr S. Strathie Page
Plasma cell vulvitis: Presentation of
a case
1430Dr P. Selva-Nayagam
Plasma cell vulvitis: Is it one
disease?
1440Dr S. Ball
On your bike! – when cycling is not
always good for you
1450Dr D. Vekic
Phenotypic variations in
hidradenitis suppurativa imply
heterogeneous pathogenic
pathways with potential adjuvant
therapeutic targets
1500
END OF SESSION
BREAKFAST SESSIONS
0730-0830LILLY AUSTRALIA SPONSORED
BREAKFAST: THE GREAT DEBATE:
GOALS OF TREATMENT FOR
SEVERE PSORIASIS – DO WE
NEED TO REDEFINE THEM?
Chairs: A/Prof. P. Foley and Dr W.
Weightman
0830
END OF SESSION
0730-0830LEO PHARMA SPONSORED
BREAKFAST: OPTIMISING PATIENT
OUTCOMES WITH PICATO® GEL:
HOW FAR CAN IT GO?
Chair: Dr S. Smith
An interactive session on improving
patient satisfaction within the clinic
setting.
0830
END OF SESSION
HALL H
1100-1230VIRTUAL CLINICAL MEETING
Hall L
Chairs: Dr E. Ryan and Dr R. Manifold
A variety of interesting clinical cases
will be presented for diagnosis and
discussion of management.
1230
END OF SESSION
1230-1400LUNCH IN TRADE EXHIBITION,
HALL H
CONCURRENT SESSION S
BREAKFAST SESSIONS
Monday 18 May 2015
1400-1500CONCURRENT SESSION 5A: FREE
PAPERS SESSION
Hall M
Chair: Dr K. Newland
1400Dr A. Chong
Dermatology teaching in Australian
medical schools: Preliminary survey
results
1415Dr J. Kern
Multicentric reticulohistiocytosis:
Rituximab as an alternative to
established therapy regimens
1430Dr D. Dyall-Smith
A family in Wagga Wagga
1445Dr C. de Belilovsky
EV.E.I.L.S PROGRAM: Ramanspectroscopic electron and genomic
characterization of newborn and
children skin physiology
1500
END OF SESSION
1530-1700ANNUAL
GENERAL
MEETING
Hall L
For Fellows and
Associate Members
of College only.
1700
END OF SESSION
C O N C U RREN T S ES S IO N S
AFTERNOON TEA IN TRADE EXHIBITION, HALL H
1530-1700REGISTRARS’ TEACHING SESSION
Hall M
Chairs: Dr S.Khoury and Dr C. Maiolo
1530Prof. A. Pandya
Update on autoimmune blistering conditions
1600Prof. A. Yan
Approaches to diagnosing genetic skin disease
1630Prof. M. Maurer
Mastocytosis - present and future treatment options
For vocational trainees in dermatology only.
1700
END OF SESSION
1700-1830CELGENE SPONSORED SYMPOSIUM:
UNDERSTANDING UNMET NEEDS IN
PSORIASIS, PSORIATIC ARTHRITIS AND
SMALL MOLECULE ORAL TREATMENT
OPTIONS
Hall L
Chair: A/Prof. P. Foley
Session objectives:
-Understand unmet physician and patient
needs in psoriasis and psoriatic arthritis
-Understand the pathophysiology and
mechanisms of disease of psoriasis and
psoriatic arthritis
-Review the efficacy and safety for small
molecule oral therapies for adults with
moderate to severe plaque psoriasis
-Identify distinctive features of psoriatic
arthritis and implications for clinical
management
1700
Arrival canapés and registration
Introduction and program objectives
Physician and patient unmet needs in
psoriasis and psoriatic arthritis
1740A/Prof. P. Nash
Intracellular cytokine signaling pathways:
A rational target in psoriasis and psoriatic
arthritis
Small molecule oral therapies for psoriasis
1820A/Prof. P. Foley and A/Prof. P. Nash
Questions
1830
END OF SESSION
1830-2000
CONCURRENT SESSIONS
CONCURRENT SESSIONS
C O N C U RREN T S ES S IO N S
1500-1530
1700-1800CYNOSURE
SPONSORED
SYMPOSIUM:
THE LATEST
ADVANCEMENTS
IN AESTHETIC
PICOSECOND
TECHNOLOGIES
Hall M
Speaker: Dr E. Tanghetti
Refreshments on
arrival.
1800
END OF SESSION
GENIE MEETING, HALL M
1800-2000
MEN’S AND LADIES TENNIS TOURNAMENT
Venue: N
ext Generation Health and Racquet Club
War Memorial Drive
NORTH ADELAIDE
T 08 8110 7777
Meet at ACD Registration Desk at 1730.
23
A U S T R A L A S I A N S O C I E T Y O F C O S M E T I C D E R M AT O L O G I S T S 2 N D A N N U A L M E E T I N G
The scientific sessions of the meeting are held in Hall N.
Monday 18 May 2015
1000–1045SESSION 1: HOW TO START A
COSMETIC PRACTICE AND HOW TO
APPROACH A COSMETIC PATIENT
Chairs: Dr B. Welsh and Dr N. Wines
1000Dr B. Welsh/Dr B.Pruim
Stories from the front line – showcasing
practices
1015Dr J. Green
Starting injectables and cosmetic pearls
1030
Panel discussion
1045
END OF SESSION
1045-1130SESSION 2: APPROACH TO THE
PATIENT: UNDERSTANDING AND
ASSESSMENT OF THE COSMETIC
PATIENT
Chairs: A
/Prof. G. Goodman
and Dr N. Cook
1045Dr C. Martschin
Personality profiles
1105A/Prof. G. Goodman
Patient assessment
1125Questions
1130
END OF SESION
1130–1200SESSION 3: ANATOMY OF THE FACE
AND NECK: FACIAL ANATOMY FOR
INJECTIONS AND FIELD BLOCKS,
LOCAL ANAESTHESIA AND DANGER
AREAS
Chairs: Dr M. Freeman
and A/Prof. G. Goodman
1130Dr C. Martschin
Anatomy for fillers: Tips for avoiding
complications from their use
1150Panel
Favourite anaesthetic tricks/techniques
and concerns
1200
END OF SESSION
24
1200-1300 SESSION 4: LASERS – HOW TO
INTRODUCE TO YOUR PRACTICE
Chairs: Dr R. Rosen and Dr S.
Manoharan
1200Dr J. Green
Laser introduction
1220Dr D. Lim/Dr A. Lim
What lasers / energy based technologies
to start with?
1240Dr E. Tanghetti
Vascular lasers - is there anything new? Tricks to enhance efficacy when treating
vascular lesions and two wavelength
devices 595/1064 – when to use and why
1300
END OF SESSION
1300-1400 LUNCH IN ACD TRADE EXHIBITION,
HALL H
1400–1430SESSION 5: LASERS AND SUN
DAMAGE
Chairs: Dr A. Sheridan and Dr S.W.
Lim
1400Dr E. Tanghetti
PDL versus IPL versus fractional for
photodamage
1415Dr J. Green
Combined laser modalities for
photodamage
1425Questions
1430
END OF SESSION
1430-1530SESSION 6: SPEED DATING AND
AFTERNOON TEA WITH TRADE, HALL H
8 minute trade talks in exhibition area
1530
END OF SESSION
1700-1830SESSION 7: INJECTING DUMMY
SESSION
Galderma team to conduct injecting
dummy session with consultants and
teams of registrars (Dr C. Martschin and
local faculty)
1830
END OF SESSION
BREAKFAST SESSIONS
0730-0830GALDERMA
SPONSORED
BREAKFAST:
FROM LAMP TO
LIGHT: HOW
TO PERFORM
DAYLIGHT
ACTIVATED PDT
City Rooms 1, 2,
3 and 4
Chair: Dr L.
Spelman
0830
END OF SESSION
0730-0830CUTERA AUSTRALIA PTY LTD SPONSORED
BREAKFAST: THE LASER DERMATOLOGY
EXPERIENCE USING PICO, NANO AND MILLI
SECOND TECHNOLOGY IN CONJUNCTION
WITH 532NM AND 1064NM WAVELENGTHS
Speaker: Dr J.B. Greene
Dr Jeremy Green will present two of the most
popular wavelengths in dermatology, 532nm KTP
and 1064nm Nd:YAG for treatment of tattoos,
pigmented lesions and vascular conditions. Dr Green
will introduce Cutera’s Enlighten dual wavelength
laser with the ability to produce pico second and
nano second pulse durations in a single system. Dr
Green will also present on the variety of conditions
that can be treated with the new gold standard for
vascular lesions, Cutera’s Excel V.
0830
END OF SESSION
0845-1015CONCURRENT SESSION 6A: GLOBAL
DERMATOLOGY SYMPOSIUM
Hall L
Chair: Dr G. Marshman
0845Dr G. Marshman
History of the International Dermatology Outreach
Committee
0850Dr C. Grills/Dr C. Wong
India
0900 Dr A. Howard
Out of Africa
0910 Dr G. Marshman
West Timor – lessons for a dermatologist
0920 Dr L. Romani
Systematic review of the global prevalence of
scabies and impetigo
0930 Dr M. Whitfeld
Skin cancer prevention and education: First Fijian
Albinism workshop
0940 Dr N. Wines
Dermatology and Ubuntu
0950 Dr P. Kumarasinghe
Quiz - cases
1000Questions
1015
END OF SESSION
HALL H
1045-1200“WHAT’S CAUGHT MY EYE” – AN
UPDATE SESSION
Hall L
Chair: Dr G. Marshman
1045Dr C. Duguid
Non melanoma skin cancers
1057A/Prof. J.W. Kelly
Melanoma
1110Dr J-A. See
Acne/rosacea/hidradenitis suppurativa
1122Dr L. Warren
Immunobullous conditions/
genodermatoses
1135Dr J. Wayte
Eczema/urticarial disorders
1147A/Prof. S. Zagarella
Drug reactions
1200
END OF SESSION
BREAKFAST SESSIONS
Tuesday 19 May 2015
0845-1015CONCURRENT
SESSION 6B: ALL
ABOUT ACNE:
ERUPTIONS ON
THE ACNE FRONT
– CONTROVERSIES
AND CHALLENGES
Hall L OR Hall M
Chair: Dr J-A. See
Presentations and
panel discussions
covering what’s new,
what’s changed and
what continues to
baffle us!
Presenters: Dr J-A. See
A/Prof. K Gebauer
Dr B. De’Ambrosis
Dr M. Tam
Dr I. McCrossin
and more
1015
END OF SESSION
1200-1330LUNCH IN TRADE EXHIBITION, HALL H
1330-1345CONTINUING PROFESSIONAL
DEVELOPMENT
Hall L
Presenter: D
r T. Wiadrowski
Member of the ACD CPD
Committee
1345
END OF SESSION
Hall L
Chair: A/Prof. C. Baker
1345Prof. A. Yan
The year in review: Update on paediatric
dermatology
1415Prof. A. Yan
Inpatient consultative paediatric
dermatology
1445
END OF SESSION
1445-1500 PRESENTATION OF AWARDS AND
CLOSING REMARKS
Hall L
25
0930-1130PRIVATE TOUR OF ADELAIDE CENTRAL
MARKET AND BREAKFAST
1230-GOLF
Venue: R
oyal Adelaide Golf Club
328 Tapleys Hill Road
SEATON
T 08 8356 5511
Tee off: 1300 hours.
A U S T R A L A S I A N S O C I E T Y O F C O S M E T I C D E R M AT O L O G I S T S 2 N D A N N U A L M E E T I N G
The scientific sessions of the meeting are held in Hall N.
Tuesday 19 May 2015
1330-1400LUNCH IN ACD TRADE EXHIBITION,
HALL H
0845–0945SESSION 8: INTRODUCTION TO SKIN
CARE AND SKIN CARE PANEL
Chairs: Dr K. Armour and Dr A. Rudd
0845A/Prof. S. Zagarella
Should we sell skincare in our practices?
0855Dr N. Wines
Nutraceuticals
0905
Panel discussion 1400-1445SESSION 10: BOTULINUM TOXIN
(CONTINUED)
Chairs: Dr L-M. Yap
and Dr E. Dawes-Higgs
1400Dr T. Walker
Avoiding neurotoxin complications
1415Expert panel
Difficult cases
1445
END OF SESSION
Industry Input
0920Mr R. Parker,Rationale
New technology in sunscreens
0925Ms I. Ciavarra, Obagi Skin Care
Eye Creams
0930Ms T. Vinson, Synergie
Mineral Make Up
0935
Panel discussion
0945
END OF SESSION
1445-1530SESSION 11: LASERS
Chairs: Dr D. Lim and Dr P. Bekhor
1445Dr E. Tanghetti
Superficial fractional Picosecond with
focus handpiece for rejuvenation
1505Dr J. Green
Short pulsed lasers
1525Questions
1530
END OF SESSION
0945–1030 SESSION 9: FILLERS
Chairs: Dr M. Rich and Dr A. Lim
0945Dr C. Martschin
Skin boosters and Emervel range
1005Dr T. Walker
Pushing the boundaries: Radiesse
injection beyond the face: Hyper dilution
for neck and arm
1025Questions
1030
END OF SESSION
HALL H
1100–1215 SESSION 9: FILLERS (CONTINUED
Panel: international and local speakers
1100
Upper face
1125
Mid face
1150
Lower face
1215
END OF SESSION
1215-1300SESSION 10: BOTULINUM TOXIN
Chairs: D
r L-M. Yap
and Dr E. Dawes-Higgs
1215Dr T. Walker
Combination use of filler and neurotoxin
1235Dr C. Martschin
Hyperhidrosis
1255Panel
1300
END OF SESSION
1300-1330ANNUAL GENERAL MEETING OF THE
ASCD
1530-1600
1600-1700
SESSION 12: DEBATES
1600First debate: Cryolipolysis is now the
preferred fat reduction modality for
dermatology practices in Australia
Chairs: Dr B. Pruim and Dr D. Lanzer
Affirmative: D
r B. Pruim and A/Prof. G.
Goodman
Negative: Dr D. Lanzer and Dr M. Rich
Sum up and adjudication: D
r E.
Tanghetti,
with help of
audience
1620Second Debate: Are men worth the
trouble?
Chairs: Dr C. McDonald
and Dr E. Yiasemides
Affirmative: Dr B. Welsh and Dr B. Pruim
Negative: Dr C. McDonald
and A/Prof. P. Foley
Overview of the differences between
treating men and treating women with
procedures, managing their expectations
1640
Minor but annoying complaints
Chairs: Prof. S. Richards and Dr V.
Morgan
Seb Ks, sebaceous hyperplasia, skin
tags, milia, intradermal naevi
Panels on smaller procedures
FWD, shave, snip biopsy, punch
techniques, subcision, curette
Acne scarring
1700
26
AFTERNOON TEA IN FOYER N
END OF MEETING
The following posters are on display at the meeting in Halls H and J:
1.
Dr l. Abdel-Malek
Use of adhesive retention tapes to anchor surface
sutures in random pattern flaps: Designs, plans
and options
16. Dr H.M. Cheng
Optical coherence tomography in the pre-surgical
margin delineation of Mohs surgery in infiltrative
BCC
2.
Dr M. Abikhair
Treatment refractory atopic dermatitis with
ichthyosis vulgaris responding to Omalizumab
17. Dr A. Chia
Safety of TNF-? inhibitors in HIV patients
3.
Dr S. Andrews
Tele-derm national highlights: Eruptive xanthomas
heralding type V hyperlipidaemia
18. Dr Y.Z. Chiang
Biochip immunofluorescence microscopy as a new
diagnostic tool for autoimmune blistering skin
diseases in Australia
4.
Dr S. Andrews
Tele-derm national highlights: Bullae on the
lower legs of a 90-year-old woman - a diagnostic
challenge
19. Dr D. Choi
Another chemotherapy reaction?
Hyperpigmentation due to alkylating agents
revisited
5.
Dr S. Andrews
Tele-derm national: Diagnostic highlights and
management gems
6.
Dr R. Anforth
Factors influencing the development of cutaneous
squamous cell carcinomas in patients on BRAF
inhibitor therapy
20. Dr M. Cicchiello
Radiotherapy-induced eruptive keratoacanthomas
of the face - a case of Ferguson-Smith disease
responsive to acitretin therapy
21. Dr P. Clarke
The proportion of the Australian population which
develops skin cancer
7.
Miss R. Ang
The autoimmune bullous disease quality of life and
treatment of autoimmune bullous disease quality
of life questionnaires - trends and responsiveness
22. Dr A. Collins
Secukinumab 300mg demonstrates highest
probability of efficacy than other biologics in
psoriasis: indirect comparison
8.
Miss R. Ang
The treatment intensity scoring system and
treatment adversity scoring system - two scoring
systems for treatments used in autoimmune
blistering diseases
23. Dr V. Cox
Review of the proposed pathogenic mechanisms
underlying rosacea and possible clinical
implications of vascular and inflammatory
involvement
9.
Dr S. Arnold
The Oxford University Hospital’s inpatient email
advice line
24. Dr G. Daley
Lipohypertrophy after autologous fat
transplantation for lip enhancement
10. Dr L. Byrom
Undiagnosed severe neonatal ichthyosis: The role
of genetic testing
11. Dr G. Carlos
Bullous annular lichen planus in a patient on
Pembrolizumab
12. Dr P. Chadha
Secukinumab treatment leads to proteomic and
transcriptional changes in psoriatic skin
13. Dr C. Chaptini
Durable dermatology life quality index (DLQI)
improvements in patients on biologics associated
with psoriasis areas and severity index (PASI) score
25. Dr G. Daley, Ms K. Lee and Ms K. Jadirdar
Glutathione S-transferase P1 Ile105Val
polymorphism: phenotypic characteristics and
melanoma risk
26. Dr B. Daniel
An Australian perspective on skin of colour: Results
of a national survey
27. Dr D. Daniels
Protecting the delicate skin of infants
28. Dr C. de Belilovsky
Sunflower oleodistillate: A topical PPAR-? agonist
developed for atopic dermatitis
14. Dr C. Chaptini
Gross hepatomegaly secondary to AA amyloidosis
in RDEB: An under-recognised complication
Tolerance assessment of cosmetic products
dedicated to baby’s skin: innovative approaches
using stinging test and infant epidermis model
15. Dr H.M. Cheng
Assessment of the optimal interval for digital
dermoscopy monitoring for the evaluation of
pigmented nail lesions
Identification of specific markers for epidermal
maturation in infancy leading to a new generation
of baby skin care
27
Avocado perseose, a biomimetic active ingredient
for the protection and accompaniment of infants’
skin
Anti-itching and barrier restoring effects of a Lipidreplenishing Balm on atopic dermatitis models
33. Dr K. Deen
Porphyria cutanea tarda masquerading as
epidermolysis bullosa acquisita - a report of two
cases
34. Dr L. Demediuk
Multifocal panniculitis due to Mycobacterium
Ulcerans: An unusual presentation of an
increasingly common disease
35. Mr H. Edwards
Advancement in calciphylaxis management: Report
of 3 cases
36. Mr L. Escudero Herra
Multi-country, cross-sectional study to determine
patient-specific and general beliefs toward
medication and their treatment adherence to
selected systemic therapies in 6 chronic immunemediated inflammatory diseases (ALIGN)
Safety and efficacy of Adalimumab in patients
with moderate to severe hidradenitis suppurativa:
results from first 12 weeks of PIONEER I, a phase
3, randomized, placebo-controlled trial
Efficacy and safety of Adalimumab in patients
with moderate to severe hidradenitis suppurativa:
results from PIONEER II, a phase 3 randomised
placebo-controlled trial
47. A/Prof. G. Goodman
ReCell - an automated kit for the treatment of
hypopigmentation
48. Dr K. Greive
Topical products to relieve and restore sunexposed skin
49. Dr A. Harris
Multiple cutaneous reticulohistiocytomas successfully
treated with topical PUVA combined with
intralesional injections of triamcinolone acetonide
50. Dr A. Harris
The epidermolysis bullosa disease activity and
scarring index (EBDASI) mobile phone application
51. Dr A. Harris
An analysis of the rurality of patients with
epidermolysis bullosa in Australia
52. Dr A. Harris
Combining microneedling and triamcinolone
- a novel way to increase the tolerability of
intralesional corticosteroid delivery in children with
alopecia areata
53. Dr A. Harris
Skin needling as a treatment for acne scarring: An
up to date review of the literature
54. Dr C. Higgins
Psoriasis severity is influenced by nutritional intake:
Results of a dietary and lifestyle questionnaire in
Victorian psoriasis patients
55. Miss I. Illingworth
Risk factors for melanoma in Tasmania: Can
targeted screening be achieved?
39. Dr B. Fergie
Perforating paraneoplastic granuloma annulare of
the hands and feet - two cases reported
56. Dr A. Ingham
Nasal bridge skin necrosis following regular use of
CPAP ventilation pressure mask
40. A/Prof. P. Foley
Secukinumab shows efficacy in subjects with and
without previous exposure to biologic psoriasis
therapy: Subanalysis from the phase 3 FIXTURE
study
57. Miss S. Jain
Characterising severity and responsiveness of a
new outcome measure for epidermolysis bullosa
- the epidermolysis bullosa disease activity and
scarring index
Secukinumab treatment sustains patient-reported
outcome benefits through 1 year
58. Dr J. Johnston
Ambulatory photodynamic therapy
Tofacitinib withdrawal and retreatment in
moderate-to-severe chronic plaque psoriasis: A
Phase 3 randomized trial
Long-term safety and tolerability of Apremilast in
patients with psoriasis: pooled safety analysis of
the ESTEEM 1 and 2 trials
44. Dr S. Gabizon
Statins reduce the risk of melanoma: Truth or myth?
45. Dr D. Gaffney
Clear cell renal carcinoma presenting as a skin
papule on the nose: A rare presentation with
variable prognosis
28
46. Dr A. Gin
Trichodysplasia spinulosa
59. Dr H. Jones
Validation of the physician global assessment and
BSA composite tool as an alternative to the PASI
for psoriasis assessments
60. Dr C. Kalai
Cross-reactivity between multiple classes of topical
corticosteroids in a treatment-resistant groin
dermatitis
61. Dr M. Khalesi
Comparison of P53, COX-2, PTCH1 and Ki67
gene expression patterns between basal cell
carcinomas at different anatomical sites and of
different subtypes
62. Dr B. Kim
How sunSmart are Australian women?
63. Dr J. Kim
Cyclical inguinal keratoderma: A new clinical
entity?
64. Dr J. Kim
Dystrophic calcinosis cutis in the setting of a
myositis/scleroderma overlap syndrome
65. Dr J. Kim
Cutaneous alternaria infection of the hand in an
immunocompromised patient
66. Dr J. Kim
Facial follicular porokeratosis: Two cases from
Western Australia
67. Dr M. Kim
Squamous cell carcinoma in recessive dystrophic
epidermolysis bullosa has high metastasis potential
due to a permissive tumour microenvironment
68. Dr A. Lalji
Diabetes mellitus and necrobiosis lipodica
69. Dr Q. Le
A single-institution experience of paediatric
melanoma in Victoria, Australia
70. Dr A. Lee
Fractional carbon dioxide laser in recalcitrant
vulval lichen sclerosus
71. Dr P.A. Lee
Cardiac medications in dermatology- a review of
the literature
72. Dr N. Linklater
Case of atypical Sweet’s syndrome
73. Dr N. Linklater
Case report of a full thickness burn following the
use of a Chlorhexidine patch
74. Dr N. Linklater
Case of Toxic epidermal necrolysis following a
dogbite
82. Dr R. McQualter
Maintenance of clinical response with long-term
brodalumab (AMG 827) therapy for psoriasis:
week 144 results from an open-label extension
study
83. Dr R. Meani
Emergence of chemoresistance in a metastatic
basal cell carcinoma patient after complete
response to hedgehog pathway inhibitor
Vismodegib (GDC-0449)
84. Dr R. Meani
Review of the Victorian Melanoma Service - A
statewide multidisciplinary melanoma referral
centre
85. Dr F. Menz
A retrospective study of psoriasis patients treated
with long contact dithranol in a dermatology day
unit
86. Dr R. Minocha
Systemic and erythrodermic reaction following
repeated exposure to bites from the common bed
bug, Cimex lectularius
87. Dr R. Minocha
Interstitial granulomatous dermatitis presenting
with scleroderma-like changes associated with
dystrophic calcification and a review of the
literature
88. Dr R. Minocha
Necrobiotic xanthogranuloma: A report of two
unique cases
89. Dr R. Minocha
The progressive clinical course of Cimicosis; the
dermatological affects from the common bed bug,
Cimex lectularius
90. Dr E. Mooney
Chromonychia: A brief review
75. Dr N. Linklater
Melanoma - The Royal Hobart Hospital experience
91. Dr E. Mooney
Kaposi’s sarcoma
76. Dr H. Lolatgis
Pigmented purpuric eruption following the lines of
blaschko in a child
92. Dr D. Norris
Treatment of granuloma faciale with intralesional
Kenacort-A 10 and 5-Fluorouracil combination
therapy
77. Dr J. Ma
Tiger, tiger: A dermatomal distribution of AGEP
78. Dr N. Maher
Disseminated mycobacterium chelonae infection
93. Dr D. Norris
Reduced levels of self-reported psychological
distress associated with multidisciplinary
melanoma clinic attendance
79. Dr C. Maiolo
Complications of Hydroxyurea therapy:
Dermatology the key to diagnosis
94. Dr D. Norris
Dermatology life quality index in the Australian
psoriasis population
80. Dr R. McQualter
Three IL-17 ligands contribute to psoriasis:
Blockade of IL-17RA signalling with brodalumab
95. Dr A. O’Connor
Stewart-Bluefarb syndrome secondary to
arteriovenous malformations and acquired nontraumatic arteriovenous fistula: Report of five cases
and a review of literature
81. Dr R. McQualter
Improvement of psoriasis in subjects with and
without psoriatic arthritis: subanalysis of a
brodalumab (AMG 827) phase 2 study for
moderate to severe plaque psoriasis (PsO)
96. Dr N. Ong
My patient has loss of MSH2 and 6 in their
sebaceous adenoma; do they have Muir Torre
syndrome?
29
97. Dr N. Ong
Molecular profiles of reticular and globular naevus
patterns: A pilot study
114. Dr C. Rowe
Psychological impact of chronic childhood skin
disease on caregivers and families: a review
98. Dr N. Ong
A clinical audit of high-cost approved drugs in
dermatology: 2003 - 2013
115. Dr C. Rowe
Immune cell infiltrate subtypes inform on
melanoma survival in stage Ib and II melanomas
99. Dr G. Parham
Understanding longitudinal melanonychia
116. Dr A. Sahebian
A review on uncommon malignancies associated
with dermatomyositis
100. Dr G.Parham
Linear erythematous cutaneous adverse reaction
during intravenous Iloprost administration
101. Dr P. Peters
Adult Blaschkitis: An unusual unilateral presentation
102. Dr L. Pitney
Intermittent combined low dose UVA1/
narrow band UVB therapy for cutaneous T-Cell
lymphoma/Sezary syndrome: Report of a case
and discussion of its implications
103. Dr L. Pitney
Scleredema of Buschke: A report of associated
acute bowel obstruction and review of systemic
complications
104. Dr F. Poon
Severe erosive lichen planus of the penis treated
effectively with oral acitretin
105. Dr F. Poon
Return of the great masquerader: A review of the
resurgence of Syphilis in Australia through clinical
vignettes
106. Dr F. Poon
The impact of an outpatients’ online handover
tool: Timely follow-up and safe patient care in the
Dermatology Department at The Royal Melbourne
Hospital
107. Dr H. Rajgopal Bala
Two cases of acute amoxycillin induced follicular
pustulosis
108. Dr J. Raymond
Congenital Becker’s naevus - a case report and
literature review
109. Dr J. Read
Familial melanoma and links with other cancers
110. Dr S. Richter
Apremilast, an oral phosphodiesterase 4 inhibitor,
in patients with moderate to severe psoriasis: 52week results of the ESTEEM 2 trial
111. Dr S. Richter
Apremilast, an oral phosphodiesterase 4 inhibitor,
in patients with nail, scalp, and palmoplantar
psoriasis: 52-week ESTEEM 2 study results
112. Ms L. Romani
Scabies and impetigo prevalence and risk factors
in Fiji: a national survey
113. Dr A. Ross
Cognitive function in patients with psoriasis while
on biologic therapies: Pilot study
30
117. Dr A. Sahebian
Prevalence of actinic keratosis and the risk factors
for skin cancer in lung transplant recipients in
Queensland, Australia
118. Dr R. Saunderson
Palisading neutrophilic granulomatous dermatitis
secondary to a novel anti-diabetic medication,
dapagliflozin
119. Dr R. Saunderson
Antibiotic therapy for Staphylococcus aureus
colonised vascular catheter tips and the occurrence
of bacteraemia - implications for hospital policy
120. Mr A. Shahnam
Sun protection practices of undergraduate
university students
121. Dr S. Shen
The unique clinical behaviour of desmoplastic
melanoma
122. A/Prof. S. Shumack, OAM
Secukinumab shows efficacy in subjects with and
without previous exposure to biologic psoriasis
therapy: Subanalysis from the phase 3 FIXTURE
study
123. Prof. R. Sinclair
Psoriasis patients with PASI90 response achieve
greater health-related quality of life improvements
than those with PASI75 response
124. Dr S. Sinnya
Use of mobile app for patient information in solid
organ transplantation - minimising gaps in patient
education
125. Dr S. Sinnya
Emergence of squamous cell carcinomas post
Nilotinib therapy for chronic myelogenous
leukemia - a rare adverse effect of a second
generation tyrosine kinase inhibitor
126. Dr E. Smith
Cutaneous melioidosis
127. Dr S. Smith
Assessment of the attitude of dermatologists to the
use of topical corticosteroids in paediatric atopic
dermatitis
128. Dr S. Smith
Assessment of attitudes towards sun-protective
behaviour in Australia: A cross-sectional study
129. Dr S. Smithson
Trends In thickness and survival of primary in situ and
invasive cutaneous melanoma In Victoria, Australia
130. Dr S. Smithson
Prognosis of melanoma of unknown primary
131. Dr P. Sobarun
Porphyria cutanea tarda in a patient on
haemodialysis and iron deficiency
132. Dr S. Sokolovska
Outcomes of pemphigus treatments at the
Royal Melbourne Hospital over 5 years on
immunosuppressive therapies used over this time:
a retrospective analysis
133. Dr S. Sokolovska
Treatment of Behcets disease with subcutaneous
testosterone: A case report
134. Dr L. Spelman
Secukinumab treatment provides fast relief from
patient-reported psoriasis burden
135. Dr L. Spelman
Secukinumab shows efficacy regardless of baseline
disease severity in subjects with moderate-tosevere plaque psoriasis: A pooled analysis from
four phase 3 studies
136. Dr S. Strathie Page
Mycophenolic acid: Applications in dermatology
Ulcerated rapidly involuting congenital
hemangiomas: A case series
Acrodermatitis dysmetabolica
Wiskott-Aldrich syndrome in an Australian population
140. Dr A. Suters
Improvement in nail psoriasis in the open-label
extension of a phase-2 trial of ixekizumab in
patients with moderate-to-severe plaque psoriasis
141. Dr A. Suters
Effects of ixekizumab treatment on quality of life
during 48 weeks of open-label treatment in a
phase-2 trial in psoriasis
142. Dr A. Suters
Impact of ixekizumab on blood neutrophil levels
and the incidence of infections caused by Candida
albicans or Staphylococcus aureus
143. Dr A. Tan
Non-bullous lichen planus pemphigoides likely
induced by venlafaxine
144. Dr A. Tan
A typical presentation of hypomelanosis of ito - a
rare pigmentary chromosomal mosaicism
145. Dr A. Tan
Allergic contact dermatitis and systemic symptoms
from wearing the new navy blue South Australian
police uniform
146. Dr J-M. Tan
Histopathological features after topical black salve
application
147. Dr J-M. Tan
Eosinophilic folliculitis in a patient receiving
chemotherapy for chronic lymphocytic leukaemia case report and review of the literature
148. Dr J-M. Tan
Localised neutrophilic eccrine hidradenitis
secondary to 5-Fluorouracil infusion for mixed
adenoneuroendocrine tumour
149. Dr J-M. Tan
A case of carbimazole-induced lichenoid drug
eruption
150. Dr W.P. Tan
The perialar cresenteric advancement flap - a
versatile flap for repair of nasal dorsum and upper
cutaneous lip defects
151. Dr C. Thomas
A case of mistaken identity: unilateral erythema
elevatum diutinum associated with IgA
paraproteinaemia
152. Dr C. Thomas
The physician who knows syphilis knows medicine:
Secondary syphilis masquerading as pityriasis rosea
153. Dr C. Thomas
MEK-Inhibitor induced compound skin toxicity with
oedema in metastatic malignant melanoma: A
case series
154. Dr B. Thompson
Skin infection secondary to Purpureocillium
lilacinum associated with a spider bite in an
immunocompetent patient - a rare case report
155. Dr A. Thornton
Background exercise and creatine kinase levels in
acne patients commencing isotretinoin
156. Dr S. Tizi
Oculocutaneous Tyrosinaemia - a case report of a
late diagnosis at age 17.
157. Dr N. Torkamani
Cells expressing epidermal stem cell markers
are exclusively localised at the distal end of the
arrector pili muscle in non-glabrous skin
158. Dr E. Trowbridge
Congenital cutaneous candidiasis: A rare neonatal
disease
159. Dr L. von Schuckmann
Vitamin D receptor polymorphisms and
keratinocyte skin cancers: A cohort study and
meta-analysis
160. Dr L. von Schuckmann
Body hair density and risk of keratinocyte skin
cancer in Australian adults
161. Dr A. Wallett
Radiation therapy induced neuro-Sweet’s disease
in a patient with oral squamous cell carcinoma
162. Dr G. Whiting
General practice registrars’ clinical experience of
dermatology during training: A cross-sectional
analysis from the registrar clinical encounters in
training study
31
163. Miss A. Wijayanti
Validity, reliability, responsiveness and minimal
clinically important difference of the bullous
pemphigoid disease area index (BPDAI)
164. Dr G. Winkler
The use of biologic agents for hidradenitis
suppurativa by Australian Dermatologists
165. Dr C. Wong
Teledermatology: A one year experience from a
Victorian tertiary hospital.
166. Dr A. Wylie
Secukinumab shows sustained response in subjects
with moderate-to-severe plaque psoriasis: A
subanalysis of the ERASURE phase 3 study
167. Dr C. Xie
Understanding pathogenesis of discoid lupus
erythematosus in chronic granulomatous disease
168. Dr C. Xie
Scalp melanoma - distinctive high risk clinical and
histological features
169. Dr B. Yau
Cutaneous SCC with dermal lymphatic spread:
When surgery is not enough
170. Dr C. Zhao
Telogen effluvium and Beau’s lines induced by
azathioprine: A case report
171. Dr C. Zhao
Severe ingenol mebutate skin reaction while on
methotrexate: A case series and proposal of
pathogenesis
172. Dr C. Zhao
Chlorophyll-induced pseudoporphyria with
ongoing photosensitivity after cessation - a case
series of 5 patients
173. Dr C. Zhao
Assessing skin diseases in patients with pigmented
skin - A grey area
174. Dr C. Zhao
Recording of dermatology consults in discharge
summaries: An analysis of 218 consults
175. Dr C. Zhao
A prospective comparison study of four outcome
measures for atopic dermatitis
32
Stand
NumberCompany
1
Australasian College of Dermatologists
2
Novartis Pharmaceuticals
3
Novartis Pharmaceuticals
4
Mayne Pharma
5Beijing Sincoheren S&T Development.
Co.,Ltd / Ausmed International Pty Ltd
6
GlaxoSmithKline Australia
7
GlaxoSmithKline Australia
8
Simes Australia Pty Ltd
9Scanmedics
10Merz
11Celgene
12Celgene
13Celgene
14Celgene
15
Australian Dermatology Equipment
16Vorotek
17
MoleMap by Dermatologists
18
Spirit Healthcare
19
Johnson & Johnson Pacific
20
Johnson & Johnson Pacific
20A
Cosmetiques de France
21A
BOQ Specialist Bank Limited
21
Macquarie Medical Systems
22
Aspen Pharma
23
Pfizer Australia
24
Pfizer Australia
25
Synergie Skin
26
Australian Ultra Violet Services Pty Ltd
27
Janssen-Cilag Pty Ltd
28
29
30
31
32
33
Expanscience Laboratories
34
Leo Pharma Pty Ltd
35
Leo Pharma Pty Ltd
36
Device Consulting
37Dermocosmetica
38Avene
39Avene
40
Nice Pak Products
41
Key Pharmaceuticals
42Formac Products – AllergEnd / Orbis
Australasia Pty Ltd
43
High Tech Laser Australia
44
Heine Australia Pty Ltd
45
Differentia Pty Ltd (Rationale)
46
Differentia Pty Ltd (Rationale)
47
Meda Pharmaceuticals
48
Cryomed Australia
49
Cryomed Australia
50
Advanced Skin Technology
51
Novartis Pharma Australia Pty Ltd
52
53
54
55
56
57
Ego Pharmaceuticals Pty Ltd
58
59
60
61
Galderma Australia Pty Ltd
62
63
64
65
66
67Cynosure
68
Realderma Pty Ltd (Neostrata)
69
Avita Medical
70Cynosure
71
AbbVie Pty Ltd
72
AbbVie Pty Ltd
73
AbbVie Pty Ltd
74
AbbVie Pty Ltd
75
La Roche Posay (l’Oreal)
76
Medifit Design & Construction
77
Pierre Fabre Australia
78
La Roche Posay (l’Oreal)
79
Ionia Medical Pty Ltd
80DermRx
81
Bayer Australia Limited
82
Eastlakes Pharmacy
83
Cutera Australia Pty Ltd
84
BrightSky Australia
85
Lumenis (Australia) Pty Ltd
86
Cutera Australia Pty Ltd
87
Allergan Australia
88
Allergan Australia
89
Merck Sharpe & Dohme
90Syneron Candela
(Candela Corporation (Australia) Pty Ltd)
Support Groups
T1
Skin & Cancer Foundation Australia
T2
Skin and Cancer Foundation Inc.
T3Australasian Blistering Diseases
Foundation
T4
Australia Alopecia Areata Foundation
T5Australian Gorlin Syndrome Mutual
Support Group
T6
Eczema Association of Australasia Inc.
T7
Nevus Support Australia Inc.
T8
Vitiligo Association of Australia
33
The Australasian College of Dermatologists kindly acknowledges
the generous support of the following sponsors in assisting with the
Annual Scientific Meeting:
Platinum Sponsor
Gold Sponsors
Others
34
THE
OFDERMATOLOGISTS
DERMATOLOGISTS
THEAUSTRALASIAN
AUSTRALASIAN COLLEGE
COLLEGE OF
48TH
ANNUAL
SCIENTIFIC
MEETING
48th
ANNUAL
SCIENTIFIC
MEETING
2015
Please note that Annual Scientific Meeting and the
Trade Exhibition are managed on behalf of the College
by ACD Educational Enterprises Pty Ltd as Trustee for
the ACD Educational Enterprises Unit Trust.
ACD Educational Enterprises Pty Ltd as Trustee for
the ACD Educational Enterprises Unit Trust
PO Box 3785, RHODES NSW 2138, Australia
T +61 2 8765 0242
or 1300 361 821 (within Australia only)
F +61 2 9736 2194
E [email protected]
W http://www.dermcoll.edu.au
35
Is anythIng more Important than touch?
Learn more at the noVartIs stanD
News for your patients with moderate to severe plaque psoriasis.
Novartis Pharmaceuticals Australia Pty Ltd, 54 Waterloo Road, North Ryde NSW 2113.
ABN 18 004 244 160 Date of preparation: April 2015 DERM0012 SKM0118

Program - The Australasian College of Dermatologists

Transcription

Similar documents

Exhibition–Bazaar of New Russian and West Literature

AVS24 2.4 GHZ Wireless Audio/Video Sender

Workshop on Case Method of Teaching at ICFAI University

ICU promo flyer final - Hospital zum Heiligen Geist Kempen

Download_file - National Committee of the Medicines and Medical

Call for Presentations

29 April 2016

08 - Rohrbasser - Electrophorese capillaire_projet PHARMELP

TREPSEA 2016 - Institut Teknologi Bandung

Time Table, Friday (11.7.2014) Pickup at 9:15 at the Hotel by Dr